Dr. Adam Kaplin is our Co-Founder, CEO and a distinguished neuropsychiatrist. Trained at both Yale and Johns Hopkins, he brings a unique blend of extensive startup experience and deep expertise in central nervous system (CNS) drug development. Dr. Kaplin is passionately committed to advancing innovative and groundbreaking treatments for neurological and psychiatric disorders. His visionary leadership continues to inspire and drive the mission of Nousynapse Pharmaceuticals forward.